Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $102.9000 (1.74%) ($100.5700 - $103.5000) on Fri. May. 11, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.51% (three month average) | RSI | 30 | Latest Price | $102.9000(1.74%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR declines -3.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(45%) IBB(44%) XBI(43%) VFMO(40%) VT(40%) | Factors Impacting UTHR price | UTHR will decline at least -1.255% in a week (0% probabilities). VIXM(-13%) TLT(-13%) UUP(-10%) VXX(-3%) TIP(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.255% (StdDev 2.51%) | Hourly BBV | 0 () | Intraday Trend | 1.2% | | | |
|
1 - 5 Day Possible Target | $96.04(-6.67%) | Resistance Level | $107.84 | 5 Day Moving Average | $102.38(0.51%) | 10 Day Moving Average | $104.17(-1.22%) | 20 Day Moving Average | $107.84(-4.58%) | To recent high | -24.8% | To recent low | 1.7% | Market Cap | $4.564b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |